COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST

Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed. L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors OSTOVIC, Drazen, KARABORNI, Sami, LIU, Jiwen
Format Patent
LanguageEnglish
French
Published 10.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed. L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux.
AbstractList Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods of preparing the cocrystals, pharmaceutical compositions of the cocrystals, and uses of the cocrystals are disclosed. L'invention concerne des co-cristaux d'un antagoniste du récepteur de l'adénosine A2B, 3-éthyl-1-propyl-8-(1- (3- (trifluorométhyl)benzyle)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, des méthodes de préparation des co-cristaux, des compositions pharmaceutiques des co-cristaux et des utilisations des co-cristaux.
Author OSTOVIC, Drazen
KARABORNI, Sami
LIU, Jiwen
Author_xml – fullname: OSTOVIC, Drazen
– fullname: KARABORNI, Sami
– fullname: LIU, Jiwen
BookMark eNrjYmDJy89L5WQwcvZ3DooMDnH0CVbwd1Nw9FNwdHH18w_29HNVcDRyUghydXYNCPEPAsqEOLr7-3kGh_AwsKYl5hSn8kJpbgZlN9cQZw_d1IL8-NTigsTk1LzUkvhwfyMDIyMDU0NTC0tHQ2PiVAEAAvcpXQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate CO-CRISTAUX D'UN ANTAGONISTE DU RÉCEPTEUR DE L'ADÉNOSINE A2B
ExternalDocumentID WO2022051589A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2022051589A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:02:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2022051589A13
Notes Application Number: WO2021US49011
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&CC=WO&NR=2022051589A1
ParticipantIDs epo_espacenet_WO2022051589A1
PublicationCentury 2000
PublicationDate 20220310
PublicationDateYYYYMMDD 2022-03-10
PublicationDate_xml – month: 03
  year: 2022
  text: 20220310
  day: 10
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies TEON THERAPEUTICS, INC
RelatedCompanies_xml – name: TEON THERAPEUTICS, INC
Score 3.3840482
Snippet Cocrystals of an adenosine A2B receptor antagonist, 3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione, methods...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COCRYSTALS OF AN ADENOSINE A2B RECEPTOR ANTAGONIST
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220310&DB=EPODOC&locale=&CC=WO&NR=2022051589A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s06hvOjVOpyHR8EYcUGA8LAYKOI2jBFDn01K-EhPDFofx3_dApnvaW9tLru0l1-uvvQ-AG7wkcz01iWRwdSgRk2uSmWiJpBJe5EWuaZlcBzhPfX3yTB5n2qwDH-tYmCZP6HeTHBE1KkV9r5rzevn_iOU0vpWr2-QdhxZ3Xjx2xBYdK0qd6VJ07LEbMIdRkVLEbaIf_tLQdo9MC7HSDl6kjVof3Be7jktZbhoV7xB2A-RXVkfQycse7NN17bUe7E3bL29sttq3OgaFMhq-RbH1FAnMEyxfQDH6rC6cIViKLYQudYOYhUiJrXvmP0TxCVx7bkwnEk4-_9vr_JVtrlQ9hW65KPMzEDRVHw2zRFYzsyBKgkiJZ1wuDARoKc9U0ofBNk7n28kXcFB3pcZRbQDd6vMrv0RrWyVXjZB-AKamfW0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s0zjfdGr8mEqi4Y24QdnGw2JYAZlulEDV-bSUAYmJYYvD-O97INM97a3pJdf2kuvdr70PgFt0kkV3bhClJ7S2QgyhK0akR4pGRJqkia7HnSLBeeJ13WfyONWnNfhY58KUdUK_y-KIqFFz1Pe8vK-X_49YVhlbubqL3nFqce_wgSVX6FhVi0qXsjUc2D6zGJUpRdwme8EvDW133zARK-2gk90r9MF-GRZ5KctNo-IcwK6P_LL8EGpJ1oQGXfdea8LepPryxmGlfasjUCmjwVvIzXEoMUcyPQnF6LGicYZkqkMpsKntcxYghZsPzBuF_BhuHJtTV8HFZ39nnb2yzZ1qJ1DPFllyCpKudfvtOOposZESNUKkJGLRSXsI0OYi1sgZtLZxOt9OvoaGyyfj2XjkPV3AfkFSyqC1FtTzz6_kEi1vHl2VAvsBtD-AYA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COCRYSTALS+OF+AN+ADENOSINE+A2B+RECEPTOR+ANTAGONIST&rft.inventor=OSTOVIC%2C+Drazen&rft.inventor=KARABORNI%2C+Sami&rft.inventor=LIU%2C+Jiwen&rft.date=2022-03-10&rft.externalDBID=A1&rft.externalDocID=WO2022051589A1